Don't want to launch Covid vaccine under pressure, says Bhar
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Bharat Biotech, the developers of India’s ‘first’ indigenous COVID-19 vaccine COVAXIN, said it cannot rush to launch the drug as safety and quality are paramount.

The growing COVID-19 cases is putting pressure on the company to come out with a vaccine quickly, said a report by Business Standard citing Krishna Ella, Chairman and Managing Director, Bharat Biotech International.

“But for us, safety and quality are paramount. We don't want to kill more people with the wrong vaccine,” Ella said.

The Hyderabad-based pharma firm is working on developing COVAXIN in collaboration with ICMR and NIV. The vaccine has completed phase-I clinical trials against COVID-19, said the report.

Before launching the vaccine, the pharma firm wants to do clinical research of the highest standards, Ella was quoted as saying.

“We have been monitored by international agencies and communities. It's a matter of prestige for the country and for us. We won't be shortsighted on research and will produce the best quality vaccine,” said Ella.

Dr. T●●●●z H●●●●●●i and 8 others like this3 shares
Dr. R●●●●h  b●●u
Dr. R●●●●h b●●u General Medicine
Safety issue and then quality
Aug 12, 2020Like
Dr. S●●●●●m S●●●●y P●●●●●l
Dr. S●●●●●m S●●●●y P●●●●●l General Medicine
It is a matter of concern if a prestigious company is being forced to publicly comment on matters of external and internal pressure. Hopefully,the interested parties will maintain a fair distance from interfering with the process of vaccine R and D.
Aug 15, 2020Like1